Agenda:
Tuesday 22 April
08.00
Registration
09.00
Opening Keynote
Stan Yakatan, Chairman, Katan Associates
09.15
Emerging Markets Keynote
Dr Jimmy Wei, VP Business Development, Hutchinson MediPharma Limited
09.35
Finance & Investment Roundtable
Chair: Ken Noonan, Senior Partner, LEK Consulting
Panellists: Anthony Hartley, Executive Director, Investment Banking, Lehman Brothers Europe Ltd
Antoine Papiernik, Mnagaing Partner, Sofinnova Partners
Dr Axel Polack, General Partner, TVM Capital
10.25
Coffee Break
10.45
Company Presentations: Public & Private Companies
12.45
Questions to Panelists
13.00
Lunch
14.00
Company Presentations: Private Companies
16.00
Questions to Panelists
16.15 - 17.30
Specialty Pharma Roundtable
Chair: Stephanie Léouzon, Managing Director Healthcare, Credit Suisse
Panellists: Stefan Aigner, Executive Vice President Corporate Development, Alpharma Inc.
François Thomas, Managing Director, Bioserve Ltd
Jonathan Kwok, MD, European Equity Research-Pharmaceuticals, Exane BNP Paribas
Lauren Feniou, Managing Director Healthcare, Rothschild
18.30 - 21.00
Awards Reception and Dinner
 

 
Wednesday 23 April
08.30
Registration
09.00
Panel Discussion: VC Strategy
Chair: Dr Genghis Lloyd-Harris, Partner, Abingworth Management Ltd
Panellists: Dr Bruno Montanari, Principal, Atlas Venture
Dr Raj Parekh, General Partner, Advent Venture Partners
Dr Peter Johann, Partner, NGN Capital
09.50
Panel Discussion: Medical Devices
Chair: Klaus Nestler, Chief Executive Officer, BioConnect AG
Panellists: Markus Bracklo, Partner, Baigo Capital
Dr Markus Hosang, General Partner, BioMedPartners
Raphaël Wisniewski, Investment Manager, Edmond de Rothschild Investment Partners
Dr Guillaume Connan, Investment Manager, Matignon Technologies
Aris Constantinides, Investment Director, NBGI Ventures
10.35
Partnering Panel
Chair: Dimitri Dimitriou, Chief Executive Officer, DyoDelta Biosciences
Panellists: Jose Maria Romero, Vice President Transactions, Late-Stage Projects Worldwide Business Development, GlaxoSmithKline
Esteban Pombo-Villar, Head of Strategic Alliance Management EU, Novartis Pharma AG
Dr Alex Chanas, Senior Director, Worldwide Licensing and Business Development, Pfizer Inc.
11.20
Coffee Break
11.40
Big Pharma Partnering Presentations (order of presentations subject to change)
11.40
Eli Lilly: Dr Andrew Wood, Executive Director Global External R & D
11.55
GlaxoSmithKline: Jose Maria Romero, Director Worldwide Business Development
12.10
Novartis Pharma AG: Esteban Pombo-Villar, Head of Strategic Alliance Management EU
12.25
Pfizer Inc.: Dr Alex Chanas, Senior Director, Worldwide Licensing and Business Development
12.40
Merck Serono International S.A.: Roel Bulthuis, Head Venture Capital Scouting
13.05
Networking Lunch & Close of Conference
 

Back to top